Candis M. Morello

Prof. Dr. Candis M. Morello

Clinical Pharmacist Specialist, University of California San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences, La Jolla, CA 92093-0657, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in International Journal of General Medicine
Verified
Journal Article
Open access
Candis M. MorelloCandis M. Morello
Candis M. Morello
Peer reviewed article authored by (Morello CM). Read article or submit your manuscript for publishing.

16 November 2011 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
NGNasim Ghafouri
Nasim Ghafouri
JHJan D Hirsch
Jan D Hirsch
GHGholamreza Heydari
Gholamreza Heydari
Candis M. MorelloCandis M. Morello
Candis M. Morello
GKGrace Kuo
Grace Kuo
RSRenu F Singh
Renu F Singh
In recent years waterpipe smoking has become a popular practice amongst young adults in eastern Mediterranean countries, including Iran. The aim of this study was to assess waterpipe smoking perceptions and practices among first-year health sciences university students in Iran and to identify factors associated with the initiation and maintenance of waterpipe use in this population.

1 July 2015 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
PSPrashant Sakharkar
Prashant Sakharkar
MBMark Bounthavong
Mark Bounthavong
JHJan D. Hirsch
Jan D. Hirsch
Candis M. MorelloCandis M. Morello
Candis M. Morello
TCTimothy C. Chen
Timothy C. Chen
ALAnandi V Law
Anandi V Law

1 December 2010 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
LVLeonel Villa-Caballero
Leonel Villa-Caballero
Candis M. MorelloCandis M. Morello
Candis M. Morello
MCMegan E. Chynoweth
Megan E. Chynoweth
APAriadna Prieto-Rosinol
Ariadna Prieto-Rosinol
WPWilliam H. Polonsky
William H. Polonsky
SESteven V. Edelman
Steven V. Edelman

5 November 2015 in Annals of Pharmacotherapy
Verified
Journal Article
Open access
Candis M. MorelloCandis M. Morello
Candis M. Morello
MCMelissa L. D. Christopher
Melissa L. D. Christopher
LOLinda Ortega
Linda Ortega
JKJohn Khoan
John Khoan
TRTaylor Rotunno
Taylor Rotunno
JHJan D. Hirsch
Jan D. Hirsch
Background: No previous studies exist examining the impact of a short-term pharmacist-endocrinologist collaborative practice model on glycemic control in complex patients. Objective: Evaluate outcomes associated with a PharmD-Endocrinologist Diabetes Intense Medical Management (DIMM) “tune up” clinic for complex patients. Methods: A retrospective cohort study of 99 patients referred to DIMM clinic versus a comparator group of 56 primary care provider (PCP) patients meeting the same criteria (adult type 2 diabetes patients, glycosylated hemoglobin [A1C] ≥ 8%, follow-up visit within 6 months) in a Veterans Affairs Medical Center. DIMM clinic used a short-term model that coupled personalized clinical care with real-time, patient-specific diabetes education during two to four 60-minute visits over 6 months. PCP patients received usual care. Primary outcome was mean A1C change after 6 months. Secondary measures included fasting blood glucose, lipids, blood pressure, weight, body mass index, and percentage of patients meeting goals. Results: Patients in each group had an average of 8 and were taking 12 to 14 medications daily. Mean A1C (%) improvement in DIMM group was significantly greater at 6 months (−2.4 [SD = 2.1] vs −0.8 [SD = 1.7]; P < 0.001), than PCP group. Percentage meeting A1C goal levels (<7%, <8%, and <9%) was significantly greater at 3 and 6 months compared with baseline in the DIMM group ( P < 0.001) versus (only <8%) at 3 and 6 months compared with baseline in PCP group. Conclusions: The DIMM clinic “tune up” model demonstrates a successful collaborative practice which helped complex diabetes patients achieve glycemic control in a 6-month period.

11 October 2019 in Pharmacy
Verified
Journal Article
Open access
PDF file
LALinda Awdishu
Linda Awdishu
RSRenu F. Singh
Renu F. Singh
ISIla M Saunders
Ila M Saunders
FYFelix K. Yam
Felix K. Yam
JHJan D. Hirsch
Jan D. Hirsch
Candis M. MorelloCandis M. Morello
Candis M. Morello
Introduction: The scope of pharmacy practice has evolved over the last few decades to focus on the optimization of medication therapy. Despite this positive impact, the lack of reimbursement remains a significant barrier to the implementation of innovative pharmacist practice models. Summary: We describe the successful development, implementation and outcomes of three types of pharmacist collaborative care models: (1) a pharmacist with physician oversight, (2) pharmacist–interprofessional teams and (3) physician–pharmacist teams. The outcome measurement of these pharmacist care models varied from the design phase to patient volume measurement and to comprehensive quality dashboards. All of these practice models have been successfully funded by affiliated health systems or grants. Conclusions: The expansion of pharmacist services delivered by clinical faculty has several benefits to affiliated health systems: (1) significant improvements in patient care quality, (2) access to experts in specialty areas, and (3) the dissemination of outcomes with national and international recognition, increasing the visibility of the health system.